Advertisement

Essential co-factors in gastric carcinogenesis

  • D. Forman

Abstract

There is now a large body of evidence which supports the association between Helicobacter pylori infection and an increased risk of gastric cancer. This is reflected in the decision by the International Agency for Cancer Research to categorize H. pylori infection as a definite cause of human cancer1. It is, however, readily apparent that, whereas infection with H. pylori is an extremely common event, gastric cancer is a relatively rare outcome of such infection. For every 100 people infected, no more than five, and probably only one or two, are likely to develop a malignancy. This poses the problem of how to identify the small percentage of infected individuals who are at increased risk of cancer. Clearly unravelling the co-factors involved in the process may be of public health significance, and should help in improving the focus of screening programmes which have, as their objective, preventing the future occurrence of gastric cancer.

Keywords

Gastric Cancer Pylorus Infection Atrophic Gastritis Gastric Carcinogenesis Gastric Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 61: Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC; 1994.Google Scholar
  2. 2.
    Cover TL, Dooley CP, Blaser MJ. Characterisation of a human serologic response to proteins in Helicobacter pylori broth culture supematants with vacuolizing cytotoxin activity. Infect Immun. 1990;58:603–10.PubMedGoogle Scholar
  3. 3.
    Crabtree JE, Taylor JD, Wyatt JI et al. Mucosal IgA recognition of Helicobacter pylori 120kDa protein, peptic ulceration and gastric pathology. Lancet. 1991;338:332–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Crabtree JE, Wyatt JI, Sobala GM et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut. 1993;34:1339–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Tummuru MKR, Cover TL, Blaser MJ. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytoxin activity of Helicobacter pylori. Infect Immun. 1994;62:2609-13.PubMedGoogle Scholar
  6. 6.
    Kuipers EJ, Pérez-Pérez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87:1777–80.PubMedCrossRefGoogle Scholar
  7. 7.
    Kuipers EJ, Uyterlinde AM, Peña AS et al. Longterm sequelae of Helicobacter pylori gastritis. Lancet. 1995;345:1525–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Nomura A, Stemmermann GN, Chyou PH et al. Helicobacter pylori and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325:1132–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.PubMedCrossRefGoogle Scholar
  10. 10.
    Kikuchi S, Wada O, Nakajima T et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer. 1995;75:2789–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Blaser MJ, Pérez-Pérez GI, Kleanthous H et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111–15.PubMedGoogle Scholar
  12. 12.
    Parsonnet J, Friedman GD, Orentreich N et al. Infection with the type 1 phenotype of H, pylori increases risk of gastric cancer independent of corpus atrophy. Gastroenterology. 1996; 110: A221.CrossRefGoogle Scholar
  13. 13.
    Kikuchi S, Forman D, Covacci A et al. Diffuse gastric cancer in young H. pylori positive Japanese patients: lack of association with CagA status. Gut. 1996 (abstract) (In press).Google Scholar
  14. 14.
    Foerster EC, Koch P, Koch O et al. Serum response to Helicobacter pylori in primary B-cell gastric lymphoma. Gut. 1995;37(Suppl. 1):A6.CrossRefGoogle Scholar
  15. 15.
    Lee A. Helicobacter infections in laboratory animals: a model for gastric neoplasias? Ann Med. 1995;27:575–82.PubMedCrossRefGoogle Scholar
  16. 16.
    Beales ILP, Davey NJ, Pusey CD et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995;346:381–2 (letter).PubMedCrossRefGoogle Scholar
  17. 17.
    Azuma T, Konishi J, Tanaka Y et al. Contribution of HLA-DQA gene to host’s response against Helicobacter pylori. Lancet. 1994;343:542–3.PubMedCrossRefGoogle Scholar
  18. 18.
    Azuma T, Ito Y, Miyaji H et al. Immunogenetic analysis of the human leukocyte antigen DQA1 locus in patients with duodenal ulcer or chronic atrophic gastritis harbouring Helicobacter pylori. Eur J Gastroenterol Hepatol. 1995;7(Suppl. 1):S71–3.PubMedGoogle Scholar
  19. 19.
    El-Omar E, Penman I, Dorrian CA et al. Helicobacter pylori infection lowers gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut. 1993;34:1060–6.PubMedCrossRefGoogle Scholar
  20. 20.
    McColl KEL, El-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol. 1996;31(Suppl. 215):32–7.CrossRefGoogle Scholar
  21. 21.
    Dixon M. Acid, ulcers and H. pylori. Lancet. 1993;342:384–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995;55:562–5.PubMedGoogle Scholar
  23. 23.
    Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med. 1995;333:32–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Steinmetz KA, Potter JD. Vegetables, Fruit, and cancer. I. Epidemiology. Cancer Causes Control. 1991;2:325–57.PubMedCrossRefGoogle Scholar
  25. 25.
    Hansson LE, Engstrand L, Nyren O et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology. 1993;105:1098–103.PubMedGoogle Scholar
  26. 26.
    Forman D. The prevalence of Helicobacter pylori infection in gastric cancer. Aliment Pharmacol Ther. 1995;9(Suppl. 2):77–84.Google Scholar
  27. 27.
    Forman D. Are nitrates a significant risk factor in human cancer? Cancer Surv. 1989;8:443–58.PubMedGoogle Scholar
  28. 28.
    Gangolli SD, van den Brandt PA, Feron VJ et al. Nitrate, nitrite and N-nitroso compounds. Eur J Pharmacol. 1994;292:1–38.PubMedGoogle Scholar
  29. 29.
    Iyengar R, Stuehr BJ, Marietta MA. Macrophage synthesis of nitrate and N-nitrosamines: precursors and the role of the respiratory burst. Proc Natl Acad Sei USA. 1987;84:6369–73.CrossRefGoogle Scholar
  30. 30.
    Rachmilewitz D, Karmeli F, Eliakim R et al. Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients. Gut. 1994;35:1394–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Bravo LE, Mannick EE, Zhang XJ et al. Helicobacter pylori infection is associated with inducible nitric oxide synthase expression, nitrotyrosine and DNA damage. Gastroenterology. 1995; 108: A63 (abstract).Google Scholar
  32. 32.
    Rieder G, Hatz RA, Stolte M, Enders G. Inos in H. pyliri-associated gastritis — possible role in carcinogenesis. Gastroenterology. 1996; 110: A1002 (abstract).Google Scholar

Copyright information

© Kluwer Academic Publishers and Axcan Pharma 1996

Authors and Affiliations

  • D. Forman

There are no affiliations available

Personalised recommendations